Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they ...

Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...

Given the scope of the risk, attention has turned to metabolic hormones that regulate appetite, satiety, and glucose metabolism, particularly glucagon-like peptide-1 (GLP-1). Its appetite ...

Discover how the breakthrough pill orforglipron matches injectable weight loss drugs in effectiveness while offering needle-free convenience for obesity ...

Glucagon-like peptide-1 is an incretin hormone capable of cytoprotective actions that reduces ... Detailed methods for in vivo assessments of cardiac structure, hypertrophy, and function, including ...

GLP1 receptor agonists (GLP1-RAs) are drugs that mimic the effects of the incretin hormone ... glucagon release, and delaying gastric emptying. Additionally, these drugs have a longer half-life than ...

Emergency treatment with the hormone glucagon (GCG) may be needed. Researchers at the University of California, Los Angeles (UCLA) have now developed a method to encapsulate glucagon in glucose ...

To prevent and treat this condition, researchers in ACS Central Science report encapsulating the hormone glucagon. In mouse trials ... and Translational Science Institute. The American Chemical ...

To help you keep the level steady and healthy, your body makes a hormone called glucagon while you sleep and after you eat. It's made in your pancreas, a small organ above your liver, and it can ...

Glucagon, a hormone best known for promoting blood sugar production in the liver, also appears to play a key role in maintaining kidney health. When UT Southwestern Medical Center researchers ...

Chemical modifications to the glucagon sequence have allowed for greater peptide solubility, stability, circulating half-life, and understanding of the structure-function potential ... and novel ...